2026-01-26 - Analysis Report
**Company Overview:**
Huntington Ingalls Industries, Inc. is a leading global designer, builder, and operator of nuclear-powered ships and other maritime assets.

**Return Comparison:**
Cumulative return of review stock (`HII`) = **128.92%**, cumulative return of S&P 500 (`VOO`) = **126.41%**, divergence = **1.80**, relative divergence = **78.70%**

The review stock has slightly outperformed the S&P 500 with a 1.80% divergence.

**Alpha, Beta Analysis:**
| Year   | CAGR | MDD  | Alpha | Beta | Cap(B) |
|--------|------|------|-------|------|--------|
| 2016-2018 | 3.0% | 28.1% | -9.0% | 0.9 | 7.5B |
| 2017-2019 | 3.0% | 28.1% | -22.0% | 1.0 | 9.8B |
| 2018-2020 | -44.0% | 42.3% | -69.0% | 0.9 | 6.7B |
| 2019-2021 | -8.0% | 42.3% | -73.0% | 0.8 | 7.3B |
| 2020-2022 | -11.0% | 41.5% | -17.0% | 0.7 | 9.1B |
| 2021-2023 | 57.0% | 20.1% | 36.0% | 0.5 | 10.2B |
| 2022-2024 | 0.0% | 34.1% | -30.0% | 0.6 | 7.4B |
| 2023-2025 | 65.0% | 41.0% | -11.0% | 0.7 | 13.3B |

Analysis: The CAGR (`compounded annual growth rate`) of the review stock has been mostly steady between 3.0% and -44.0% across the provided periods. Beta (`sensitivity to market movements`) has been generally increasing, while Alpha (`excess return compared to the market`) has varied significantly.

**Recent Stock Price Fluctuations:**
Close = **$418.58**, 5-day SMA = **$421.38**, 20-day SMA = **$384.41**, 60-day SMA = **$339.23**

The recent price fluctuation is below the 5-day SMA and above the 20-day SMA and 60-day SMA.

**RSI, PPO, Delta_Previous_Relative_Divergence, Expected_Return Analysis:**

- Market Risk Indicator (`MRI`) = **0.70** (indicating medium risk)
- RSI = **78.00**
- PPO = **0.42**
- Recent (20 days) relative divergence change = **+0.50** (improving)
- 7-day Rank change = **0** (flat)
- 7-day Dynamic Expected Return change = **0.00** (flat)
- Expected Return = **-17.50%** (expected excess return compared to the S&P 500, if invested long-term)

Analysis: With a high RSI of 78.00 and a high PPO of 0.42, it appears the review stock is overbought. However, the increasing expected return is promising.

**Recent News & Significant Events:**

- January 25, 2026: QRG Capital Management Inc. Sells 2,410 Shares of Huntington Ingalls Industries, Inc. ($HII)
- January 25, 2026: A Look At Huntington Ingalls Industries (HII) Valuation After Major Defense Wins And USS Zumwalt Milestone
- January 12, 2026: What You Need To Know Ahead of Huntington Ingalls' Earnings Release
- January 15, 2026: Here's Why You Should Add HII Stock to Your Portfolio Right Now
- January 21, 2026: Analysts see 14% downside to Huntington Ingalls Industries, Inc. (HII)
- January 22, 2026: HII Celebrates One Year of Newport News Shipbuilding Operations in Goose Creek, SC

**Analyst Opinions:**
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.45 (~Buy)
- Opinions: 10
- Target Price (avg/high/low): 380.60 / 450.00 / 292.00

**Recent Earnings Analysis:**
| Date       | EPS | Revenue |
|------------|-----|---------|
| 2025-10-30 | 3.69 | 3.19 B$ |
| 2025-07-31 | 3.86 | 3.08 B$ |
| 2025-05-01 | 3.79 | 2.73 B$ |
| 2024-10-31 | 2.56 | 2.75 B$ |

Analysis: The review stock's recent earnings have been relatively stable, with a 12.34% profit margin in the last quarter of 2025.

**Financial Information: Revenue and Profitability**
| Quarter        | Revenue | Profit Margin |
|----------------|---------|---------------|
| 2025-09-30     | $3.19B | 12.34% |
| 2025-06-30     | $3.08B | 12.82% |
| 2025-03-31     | $2.73B | 14.41% |
| 2024-12-31     | $3.00B | 10.69% |
| 2024-09-30     | $2.75B | 11.71% |

**Capitilization and Profitability:**
| Quarter        | Equity | ROE |
|----------------|---------|-----|
| 2025-09-30     | $4.98B | 2.91% |
| 2025-06-30     | $4.88B | 3.11% |
| 2025-03-31     | $4.77B | 3.12% |
| 2024-12-31     | $4.67B | 2.64% |
| 2024-09-30     | $4.20B | 2.40% |

Analysis: The equity of the review stock has increased across the provided periods, leading to a relatively steady ROE (Return on Equity).

**Comprehensive Analysis (Summary of previous items):**

The review stock's recent performance shows a high cumulative return and medium risk. Its financials indicate stable revenues and a steady profit margin. However, its RSI and PPO suggest it might be overbought. With a negative expected return, it may be beneficial to reassess whether to hold or sell the stock.

Please note, as a neutral analytical report, the analysis here is for information purposes only and doesn't constitute investment advice.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.